Revvity
Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments.
Latest Revvity Content
App Note / Case Study
Leverage AI To Perform Cell Segmentation on Brightfield Images
This application note showcases how an AI-based module has been trained to analyze brightfield images for cell segmentation, allowing insights into cell proliferation and cell morphology without the need for manual drawing on images.
Product News
Revvity Broadens Relationship With Genomics England To Advance Genomics in the UK
Revvity, Inc. (NYSE: RVTY), announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance critical genomic initiatives across the United Kingdom.
Product News
Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories
Revvity, Inc. (NYSE: RVTY) announced the launch of Revvity Transcribe AI, an innovative optical character recognition (OCR) service designed to convert handwritten text on test request forms into a digitized format.
Product News
Revvity’s EUROIMMUN Launches Solution for Specific Typing of Alzheimer’s Disease Associated APOE Gene
APOE genotyping allows assessment of a patient’s risk for adverse effects from new anti-amyloid therapy for Alzheimer’s.
Industry Insight
Getting New Drug Modalities to Market: How Can Your Data Strategy Help?
This article explores the revolution in new drug modalities and the challenges around effective data strategies to support AI efforts.
App Note / Case Study
Optimizing miRNA Research for Low-Input Samples
This application note provides insights into innovative methodologies designed to enhance miRNA discovery and mapping from low-input samples.
Whitepaper
Harnessing AI in Cellular Imaging for Faster and Smarter Drug Discovery
This whitepaper explores how artificial intelligence (AI), machine learning (ML) and deep learning (DL) are transforming cellular imaging and drug discovery, enabling researchers to analyze complex datasets with unprecedented speed and accuracy.
App Note / Case Study
Discover Automated Tissue Homogenization for LC-MS Analysis
This application note explores how automated workstations for tissue sample weighing and homogenization can increase efficiency and quality of results.
Webinar
Real-World Insights on Cell and Gene Therapy Development: Navigating the Complexities of Critical Quality Attributes
On-Demand
In this webinar, you’ll gain insights from experts in CGT development who will explore their experiences of CQA assays, sharing advice on how to overcome the challenges you may face in your CGT journey.
Industry Insight
Next Generation Precision Genome Editing: Combining Multiple Advances To Create Safer Gene Therapies
In this article, Michelle Fraser and Amanda Haupthow discuss how engineered nucleases in combination with next-generation base editing platforms are paving the way for the development of novel treatments for genetic disorders and diseases.
Advertisement
